Ebastine in the treatment of patients with allergic rhinitis
https://doi.org/10.21518/2079-701X-2019-12-58-62
Abstract
Allergic rhinitis is a common disease that affects people regardless of age, place of residence and social status. The mucous membrane of the nasal cavity often acts as a portal for allergen entry. The latest data suggest that nearly 30% of humanity are currently suffering from AR. The prevalence of AR varies from 13 to 24% in different regions of the Russian Federation. AR is one of the main risk factors for the development of bronchial asthma, as well as its exacerbations, has a significant negativeimpact on the quality of life. Therefore, the timely start of rational therapy of AR is so important. The article focuses on the drugs for local and systemic treatment of AR, discusses the issue of prescribing different groups of drugs depending on the severity of the course of AR, and shows the pros and cons of different groups of antihistamines. Ebastine is one of the modern antihistamine drugs, to which a brief overview of the treatment of AR is devoted. We can recommend this drug for the treatment of year-round AR.
About the Authors
A. Yu. Ovchinnikov
Federal State Budgetary Educational Institution of the Higher Education Moscow State University of Medicine and Dentistry named after A.I. Yevdokimov of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
Ovchinnikov Andrey Yurievich - Dr. of Sci (Med), Professor, Head of the Department of Otorhinolaryngology.
127473, Moscow, 20, Delegateskaya St., b. 1; Tel: +7(495) 305-71-01
N. A. Miroshnichenko
Federal State Budgetary Educational Institution of the Higher Education Moscow State University of Medicine and Dentistry named after A.I. Yevdokimov of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
Miroshnichenko Nina Alexandrovna - Dr. of Sci (Med), Professor of the Department of Otorhinolaryngology.
127473, Moscow, 20, Delegateskaya St., b. 1; Tel: +7(495) 305-71-01
V. A. Simsova
Federal State Budgetary Educational Institution of the Higher Education Moscow State University of Medicine and Dentistry named after A.I. Yevdokimov of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
Simsova Viktoria Aleksandrovna - Postgraduate Student, Chair for Otorhinolaryngology.
127473, Moscow, 20, Delegateskaya St., b. 1; Tel.: +7(916) 812-86-15
References
1. Turovsky A.B., Kondrashkina V.V., Karyuk Yu.A. Step therapy of allergic rhinitis. Consilium Medicum. 2013;3:63-68. (In Russ).
2. Kryukov A.I., Gurbanov F.A. Pathogenetic therapy of allergic rhinosinusitis at the present stage. Rossiyskaya Otorinolaringologia. 2010;5(48):25-29. (In Russ).
3. Luss L.V. Factors affecting the clinical efficacy of antihistamines. Trudny Patient. 2014;4. (In Russ).
4. Nikiforova G.N., Volkova K.B., Svistushkin V.M. Role and significance of modern antihistamine drugs in treating allergic rhinitis. RMJ. 2015;23:1395-1398. (In Russ).
5. Bodnya O.S., Nenasheva N.M. To help the practitioner: management of patients with allergic rhinitis at the outpatient stage. Astma iAllergia. 2015;4:28-34. (In Russ).
6. Terekhova E.P., Terekhov D.V. Allergic rhinitis: modern therapy methods. Meditsinsky Sovet. 2016;17 (In Russ).
7. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update. Allergy (Suppl. 86). 2008;63:1-160.
Review
For citations:
Ovchinnikov AY, Miroshnichenko NA, Simsova VA. Ebastine in the treatment of patients with allergic rhinitis. Meditsinskiy sovet = Medical Council. 2019;(12):58-62. (In Russ.) https://doi.org/10.21518/2079-701X-2019-12-58-62
Views:
773
Email this article 